The crystal structure of a human endogenous reverse transcriptase has similarities to HIV reverse transcriptase, a well-known tractable drug target, which will help design drugs to treat cancer and ...
The crystal structure of a human endogenous reverse transcriptase has similarities to HIV reverse transcriptase, a well-known tractable drug target, which will help design drugs to treat cancer and ...
The HIV-2 serotype of HIV is a cause of disease in parts of the West African population, and there is evidence for its spread to Europe and Asia. HIV-2 reverse transcriptase (RT) demonstrates an ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ROME Therapeutics, a biotechnology company harnessing the power of the dark genome for drug development, today announced a new publication in The Proceedings of the ...
Soon after the discovery of HIV-1, intense efforts focused on developing drugs to tackle the virus. Early targets were the HIV-1 protease and reverse transcriptase, and drug development was greatly ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 41 (Oct. 12, 2004), pp. 14713-14718 (6 pages) Telomerase synthesizes telomeric DNA by copying a short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results